Albert; Jeffrey S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Albert; Jeffrey S..The latest application filed is for "substituted benzimidazoles, their preparation and their use as pharmaceuticals".

Company Profile

8.8.15

Albert; Jeffrey S. - Montreal CA
Albert; Jeffrey S. - Miami FL
ALBERT; Jeffrey S. - Dollard-des-Ormeaux CA
Albert; Jeffrey S. - Wilmington DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted benzimidazoles, their preparation and their use as pharmaceuticals Grant 11,365,186 - Pourashraf , et al. June 21, 2	2022-06-21
Substituted Benzimidazoles, Their Preparation And Their Use As Pharmaceuticals App 20210107893 - POURASHRAF; Mehrnaz ; et al.	2021-04-15
N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals Grant 10,836,742 - Jacquemot , et al. November 17, 2	2020-11-17
Aryl-substituted Dihydroquinolinones, Their Preparation And Their Use As Pharmaceuticals App 20200299262 - JACQUEMOT; Guillaume ; et al.	2020-09-24
Substituted Imidazopyridines, Their Preparation And Their Use As Pharmaceuticals App 20200299291 - POURASHRAF; Mehrnaz ; et al.	2020-09-24
Substituted benzimidazoles, their preparation and their use as pharmaceuticals Grant 10,703,740 - Pourashraf , et al.	2020-07-07
N-substituted Bicyclic Lactams, Their Preparation And Their Use As Pharmaceuticals App 20200024253 - JACQUEMOT; Guillaume ; et al.	2020-01-23
Aryl-substituted dihydroquinolinones, their preparation and their use as pharmaceuticals Grant 10,501,438 - Jacquemot , et al. Dec	2019-12-10
Substituted imidazo[1,2-a]pyridines as bromodomain inhibitors Grant 10,501,459 - Pourashraf , et al. Dec	2019-12-10
Rac inhibitors Grant 10,472,352 - Lippman , et al. Nov	2019-11-12
Rac Inhibitors App 20190031647 - LIPPMAN; Marc ; et al.	2019-01-31
Substituted Benzimidazoles, Their Preparation And Their Use As Pharmaceuticals App 20180237417 - POURASHRAF; Mehrnaz ; et al.	2018-08-23
Aryl-substituted Dihydroquinolinones, Their Preparation And Their Use As Pharmaceuticals App 20180230130 - JACQUEMOT; Guillaume ; et al.	2018-08-16
Oxazolo[5,4-c]quinolin-2-one Compounds As Bromodomain Inhibitors App 20160039842 - ALBERT; Jeffrey S. ; et al.	2016-02-11
Alkyl sulfoxide quinolines as NK-3 receptor ligands Grant 7,964,733 - Albert , et al. June 21, 2	2011-06-21
Alkylsulphonamide quinolines Grant 7,608,628 - Simpson , et al. October 27, 2	2009-10-27
Alkylnitrile Quinolines as Nk-3 Receptor Ligands App 20080306110 - Albert; Jeffrey S. ; et al.	2008-12-11
Alkylpyridyl Quinolines as Nk3 Receptor Modulators App 20080287492 - Albert; Jeffrey S. ; et al.	2008-11-20
Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators App 20080280949 - Albert; Jeffrey S. ; et al.	2008-11-13
N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor Ligands App 20080234269 - Campbell; James B. ; et al.	2008-09-25
Alkyl Sulfoxide Quinolines as Nk-3 Receptor Ligands App 20080214605 - Albert; Jeffrey S. ; et al.	2008-09-04
Amide Alkyl Pyridiyl Quinolines as Nk3 Receptor Modulators App 20080200504 - Albert; Jeffrey S. ; et al.	2008-08-21
Quinoline 3-Sulfonate Esters as Nk3 Receptor Modulators App 20080194622 - Simpson; Thomas R. ; et al.	2008-08-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.